Стоит ли избегать 3-benzylidene camphor при беременности? | VeriMom
Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Безопасен ли 3-benzylidene camphor при беременности?
- Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
- Безопасен ли 3-benzylidene camphor при грудном вскармливании?
- Same hazard/mechanistic evidence applies (endocrine activity, SCCS concerns; ECHA SVHC listing). Topical cosmetic application can produce measurable systemic levels for lipophilic UV‑filter type compounds, so moderate exposure to the nursing parent (and potential low‑to‑moderate transfer to milk) is plausible though direct milk‑transfer data are lacking; therefore exposure scored as moderate (E=2).
- Безопасен ли 3-benzylidene camphor для кожи малыша?
- Hazard and mechanism as above (SCCS: endocrine activity; ECHA: SVHC for endocrine disruption). Because infants 0–3 years have an immature skin barrier and higher surface‑area‑to‑body‑weight, exposure score is increased by +1 relative to adult topical exposure (adult E=2 → infant E=3). Infants may therefore be at higher internal exposure and greater sensitivity to hormonal perturbation.
- Как VeriMom оценивает 3-benzylidene camphor?
- VeriMom оценивает 3-benzylidene camphor в 13/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы 3-benzylidene camphor при беременности?
- См. наш список безопасных альтернатив 3-benzylidene camphor с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.